|

Dulaglutide Clinical Trials

2 actively recruiting trials across 1 location

Also known as: LY2189265

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Eli Lilly and Company2

Indications

  • Diabetes2
  • Type 2 Diabetes Mellitus (T2DM)1
  • Type 2 Diabetes1

Other1 trial

A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Phase 1

Tucson, Arizona1 trial

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

University of Arizona

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.